Biotechnology and Pharmaceutical Services Outsourcing Market Research Report Information By Service (Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education and Others), By End Use (Pharmaceutical and Biotechnology) And By Region (North America, Europe, Asia-Pacific, And The Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE

6.1. Overview

6.2. Consulting

6.3. Auditing & Assessment

6.4. Regulatory Affairs

6.5. Product Maintenance

6.6. Product Design & Development

6.7. Product Testing & Validation

6.8. Training & Education

6.9. Other

7. GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE

7.1. Overview

7.2. Pharmaceutical

7.3. Biotechnology

8. GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICESOUTSOURCING MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Biotechnology and Pharmaceutical Services Outsourcing Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Biotechnology and Pharmaceutical Services Outsourcing Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. The Quantic Group

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. IQVIA

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Paraxel International Corporation

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Lachman Consultant Services Inc

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. GMP Pharmaceuticals Pty Ltd

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Concept Heidelberg GmbH

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Civance Inc

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Charles River Laboratories

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. PRA Health Sciences

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. ICON plc

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICESOUTSOURCING MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICESOUTSOURCING MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICESOUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICESOUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 7 US: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 8 US: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 9 CANADA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 10 CANADA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 3 GERMANY: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 5 FRANCE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 6 FRANCE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 7 ITALY: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 8 ITALY: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 9 SPAIN: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 10 SPAIN: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 11 UK: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 12 UK: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 17 JAPAN: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 18 JAPAN: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 19 CHINA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 20 CHINA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 21 INDIA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 22 INDIA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 23 AUSTRALIA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 24 AUSTRALIA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 33 AFRICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 34 AFRICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY SERVICE, 2018-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, BY END USE, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET

FIGURE 4 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY SERVICE, 2022

FIGURE 5 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY END USE, 2022

FIGURE 6 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL SERVICES OUTSOURCING MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 THE QUANTIC GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 THE QUANTIC GROUP: SWOT ANALYSIS

FIGURE 14 IQVIA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 IQVIA: SWOT ANALYSIS

FIGURE 16 PARAXEL INTERNATIONAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 PARAXEL INTERNATIONAL CORPORATION: SWOT ANALYSIS

FIGURE 18 LACHMAN CONSULTANT SERVICES INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 LACHMAN CONSULTANT SERVICES INC: SWOT ANALYSIS

FIGURE 20 GMP PHARMACEUTICALS PTY LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 GMP PHARMACEUTICALS PTY LTD: SWOT ANALYSIS

FIGURE 22 CONCEPT HEIDELBERG GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 CONCEPT HEIDELBERG GMBH: SWOT ANALYSIS

FIGURE 24 COVANCE INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 COVANCE INC: SWOT ANALYSIS

FIGURE 26 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 CHARLES RIVER LABORATORIES: SWOT ANALYSIS

FIGURE 28 PRA HEALTH SCIENCES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 PRA HEALTH SCIENCES: SWOT ANALYSIS

FIGURE 30 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ICON PLC: SWOT ANALYSIS